Presentamos el caso de una paciente de 44 años estudiada por amenorrea e hiperprolactinemia. No refería galactorrea, cefalea ni alteraciones en la visión. HIPERPROLACTINEMIA Y PROLACTINOMA. MP Diagnóstico específico: PRL se deben medir en todo paciente con hipogonadismo o. A hiperprolactinemia causa hipogonadismo hipogonadotrófico principalmente por inibir a secreção pulsátil do GnRH, além de inibir diretamente a.

Author: Zolot Zull
Country: Cayman Islands
Language: English (Spanish)
Genre: Music
Published (Last): 28 September 2006
Pages: 85
PDF File Size: 16.96 Mb
ePub File Size: 6.60 Mb
ISBN: 834-9-56199-549-8
Downloads: 39951
Price: Free* [*Free Regsitration Required]
Uploader: Dar

Prolactin; hyperprolactinemia; prolactinoma; pseudoprolactinoma; pituitary adenoma; neurosurgery; macroprolactina; dopamine agonist. Indian J Med Res. Shimatsu A, Hattori N. Emotional aspects of hyperprolactinemia.

[Current diagnosis and treatment of hyperprolactinemia].

Pituitary tumors in pregnancy. Services on Demand Journal. It is not clear whether cabergoline is also more effective with respect to tumor growth because the certainty of the evidence is very low.

Recentemente, Mazziotti e cols. Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. A paciente deve ser monitorada clinicamente a cada trimestre. Radiotherapy for prolactin-secreting pituitary tumors. Prolactinomas in children and adolescents.


Por lo tanto, parte de la evidencia incluida en este resumen no fue considerada. A study of hiperprolacyinemia with histologically verified non-functioning pituitary macroadenoma.

J Clin Endocrinol Metab.

Trans Am Clin Climatol Assoc. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Twenty-four hour secretory patterns of prolactin in women. Vertebral body bonemineral content in hyperprolactinemic women.

Outcome of cabergoline treatment in men with prolactinoma: Macroprolactinomas can also present with symptoms and signs resulting form mass effect of the tumor, such as headaches and visual field defects. The prevalence of pituitary adenomas: Aust N Z J Ophthalmol. How to cite this article.

There was a problem providing the content you requested

Su principal desarrollo es la base de datos Epistemonikos www. Body fat in men with prolactinoma. Cabergoline Comparative Study Group. Hyperprolactinemia causes hypogonadism, menstrual irregularities or amenorrhea in women, low serum testosterone levels in men, and infertility and sexual dysfunction in both men and women. Cabergoline Comparative Study Group.

Advances in the treatment of prolactinomas. Temozolomide in the management of dopamine agonist-resistant prolactinomas. De los estudios no aleatorizados incluidos, los tres corresponden a cohortes retrospectivas.


[Current diagnosis and treatment of hyperprolactinemia].

In macroprolactinomas, management should be individualized. Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET. Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: Vertebral fractures in males with prolactinoma. Nos macroprolactinomas, o manejo deve amenordea individualizado. Prolactinomas resistant to standard doses of cabergoline: A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.


Colao A, Loche S. However, it is not clear if this translates into clinical benefits.

Multiple endocrine neoplasia type 1. Restoration of ovarian cyclicity and ovulation induction in hypopituitary women. Osteocalcin levels in patients with microprolactinoma before and during medical treatment. Spontaneous and medically induced cerebrospinal fluidleakage in the setting of pituitary adenomas:

Posted in Sex